<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82201">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01754948</url>
  </required_header>
  <id_info>
    <org_study_id>0488</org_study_id>
    <nct_id>NCT01754948</nct_id>
  </id_info>
  <brief_title>Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children</brief_title>
  <acronym>EHF</acronym>
  <official_title>Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background Ambient airborne particulate material (PM) is defined according the aerodynamic
      diameter  into coarse, fine, and ultrafine or &quot;nano&quot; sized particles ranging  between 2.5-10
      µm (coarse), &lt;2.5 µm (fine), and &lt;0.1 µm (nano(. Many studies have examined particle effect
      on respiratory health in children, mainly by environmental monitoring of coarse and fine
      particles. Biological assessment   of individual exposure to nano sized particles in
      correlation to adverse health effect was not previously studied.

      Hypothesis individual exposure to nano sized particles in children is associated with
      reduction in forced expiratory volume at one second.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Ecologic or Community, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>spirometry values</measure>
    <time_frame>1 sec</time_frame>
    <safety_issue>No</safety_issue>
    <description>forced expiratory volume at one second</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>methacholine and adenosine challenge test results</measure>
    <time_frame>1 sec</time_frame>
    <safety_issue>No</safety_issue>
    <description>provocative concentration causing a 20% fall in forced expiratory volume at one second and provocative dose causing a 20% fall in forced expiratory volume at one second</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        asthmatic and control children
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 6-18 years

          -  living in the Tel Aviv area

          -  referred to the pulmonology lab for respiratory function evaluation

        Exclusion Criteria:

          -  Exposure to cigarette smoke

          -  Respiratory infection in the 4 weeks prior to recruitment and testing
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shira Benor, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tel Aviv Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shira Benor, MD</last_name>
    <phone>+972527360276</phone>
    <email>shirabenor@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth Fireman, Phd</last_name>
    <email>lizzyf@tlvmc.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tel Aviv Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shira Benor, MD</last_name>
      <email>shirabenor@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Shira Benor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shira Benor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 20, 2012</lastchanged_date>
  <firstreceived_date>December 18, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>reactive airway disease</keyword>
  <keyword>cough</keyword>
  <keyword>air pollution</keyword>
  <keyword>nano particles</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
